A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer.
| Image |  |
|---|---|
| Description | scientific article published on 26 May 2016 |
| Author/s |
author: Douglas B Chepeha Andrew G Shuman Jeremy Michael George Taylor Carol R Bradford Alexander T Pearson Shaomeng Wang |
| Publication date | May 26, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |